Global Biopsy Devices Market
Size - Industry Trends & Outlook Report 2026
Global Biopsy Devices Market is
estimated to be USD 3.8 billion by 2026 from USD 2.53 billion in 2019, at a
CAGR of 6% from 2020 to 2026. Significant increase in cancer occurrence, such
as breast, prostate, and lung, and fast technological advancements such as 3D
optical biopsies, MRI-targeted biopsies, and Ultrasound-guided biopsies fuel
the acceptance of biopsy devices. Moreover, the rise in consciousness on the
diagnosis of chronic diseases fosters the demand for integrated biopsy
technologies such as stereotactic-guided biopsy. However, the high cost of biopsy
devices and limited accessibility of skilled professionals in low-income
countries hamper the market's development.
Global Biopsy Devices Market:
Market Outlook and Trends
The biopsy is a process to
execute surgical removal of tissue from an organ to conclude the presence or
extent of disease, generally cancerous and inflammatory conditions. It is
usually performed by surgeons, radiologists, and interventional cardiologists.
Biopsies can be executed on any organ using precise biopsy devices as a confirmatory
test for cancer and celiac diseases. The use of each biopsy device varies
according to the type of organ under consideration. Conventional biopsy devices
can complement progressive imaging technologies, such as MRI-guided biopsy,
stereotactic-guided biopsy, ultrasound-guided biopsy, CT scan, and others, to
execute biopsy with correctness and minimal invasiveness. These integrated
procedures are used to do biopsies on body organs such as the lungs, liver, and
Global Biopsy Devices Market
Rising cases of cancer
The growing occurrence of cancer
universal and the occurrence of untapped opportunities in developing economies,
especially of Asia Pacific, along with refining healthcare infrastructure in
these regions, are amid the key trends stoking market growth. Surging demand
for effective diagnostic procedures for cancer is also predictable to work in
favor of the market.
R&D in the medical field
The outline of technologically
advanced products such as the Aspiration biopsy syringe gun by INRAD Inc.
supports the section's development. Moreover, the burgeoning demand for
vacuum-assisted devices is inducing the biopsy devices market positively. These
devices are manual, semi-automatic, and automatic with a spring-loaded mechanism
for minimally invasive insertion to obtain laboratory testing samples. Such
devices prove high efficiency and accuracy in the withdrawal of large volumes
and excellent quality tissue samples with minimal passes through the skin.
Continual research and
development in medical devices have led to the introduction of various novel
gear and systems in the market, such as robotic medical systems. Robotic
guidance systems offer multiple welfares in a process such as growing the total
number of surgeries executed by a surgeon and reducing patient stay in the
hospital. These systems are used to reduce the entire procedural duration to
safeguard minimal patient discomfort.
expenditure is triggering the need for actual diagnostic procedures. Government
and healthcare regulatory bodies worldwide are engaged continuously in curbing
high costs related to the treatment of cancer. Primary and secondary healthcare
centers in emerging nations are boosting patients to experience regular
diagnostic examinations. Biopsy devices involve a comparatively lesser number
of hospital stays and, therefore, is economically viable.
Impact of COVID-19 in industry
During the COVID-19 epidemic,
screenings have fallen sharply. Cervical cancer repeats were down 68 percent in
the US across the first 15 weeks of 2020, while breast cancer checking downfall
by 17 percent, with more significant declines in areas where the outbreak was
sturdiest. Amid patients with cancer and COVID-19, 30-day all-cause humanity
was high and related to general risk factors and risk factors exclusive to
cancer patients. Longer follow-up is desirable to understand better the effect
of COVID-19 on results in patients with cancer, including the capability to
last specific cancer treatments.
Global Biopsy Devices Market:
The biopsy devices market is
segmented based on the product, application, imaging technology, end-user, and
region. The biopsy devices market is segmented into needle-based biopsy
instruments, biopsy forceps, localization wires, and other products based on
product. The needle-based biopsy instruments learned the largest biopsy devices
market share in 2018. Furthermore, this section is also predictable to grow at
the fastest rate during the estimated period due to a surge in the number of
breast cancer, gastrointestinal tract diseases, and soft tissue sarcomas.
Aspiration biopsy needles are non-invasive and provide significant sample
collection compared to core biopsy devices, which require an incision.
Furthermore, core biopsy devices are higher in cost than vacuum-assisted biopsy
devices and aspiration biopsy needles.
Based on the application, the
market is classified into breast biopsy, gastrointestinal (GI) biopsy, prostate
biopsy, liver biopsy, lung biopsy, kidney biopsy, gynecological biopsy, and
others. Based on the application, the breast biopsy in the application segment
generated the highest revenue in 2018 and is expected to maintain its supremacy
during the forecast period. This is attributed to the rise in the number of
breast cancer patients witnessed over the years throughout the globe and is
predictable to maintain this trend in the future. Presently, breast cancer can
be recognized efficiently using progressive biopsy devices with higher efficacy
in less time. Besides, the surge in the public consciousness for disease
screening and technological advancement in biopsy devices has driven the
request for the use of biopsy devices universal.
Based on imaging technology, the
market is divided into MRI-guided biopsy, stereotactic-guided biopsy,
ultrasound-guided biopsy, CT scan, and others. Based on End-user, the market is
characterized by diagnostic and imaging centers, hospitals, and others. Based
on the region, the biopsy devices market size is analyzed across North America,
Europe, Asia Pacific, South America, and the Middle East & Africa.
Global Biopsy Devices Market:
North America occupied the
largest share of the market in 2018 and is expected to maintain its dominance
during the predicted period owing to extensive accessibility of trained medical
professionals, availability of well-developed infrastructure facilities, and
the existence of mainstream of crucial players. However, Asia-Pacific is probable
to see the highest growth rate throughout the forecast period, due to its large
population base, the surge in disposable income, and the rise in patient
consciousness toward disease screening. Besides, the increase in the geriatric
population that is highly vulnerable to cancer is the crucial funder for its
The leading players in the
Biopsy Devices Market include Argon Medical Devices, Inc., B. Braun Melsungen
AG, Becton Dickinson and Company (C.R. Bard, Inc.), Boston Scientific
Corporation, Cardinal Health, Inc., Cook Medical, Inc., Danaher Corporation
(Leica Microsystem), Fujifilm Holdings Corp., Hologic, Inc., and Medtronic plc.
other prominent players.
October 2020, Argon Medical
Devices and Rex Medical announce Exclusive License and Distribution Agreement
for the “CLEANER™” Rotational Thrombectomy System.
May 2020, Cardinal Health (NYSE:
CAH) announced today that it is sending an irrevocable notice of early
redemption to the holders of the Company's $500 million 4.625% notes due 2020.
The early redemption date is set to June 22, 2020, according to the June 2,
2008 indenture and the notes.
Scope of the Report
Historical data – 2016-2018
Base Year – 2019
Forecast – 2020 – 2026
Revenue in USD Billion
U.S, Canada, Germany, UK, France, Italy,
Spain, Brazil, Mexico, Japan, South Korea, China, India, UAE, South Africa,
Saudi Arabia .
By Product, By Application, By Imaging
Technology, By End User, By Region
leading players considered for market analysis are Argon Medical Devices,
Inc., B. Braun Melsungen AG, Becton Dickinson and Company (C.R. Bard, Inc.),
Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical, Inc.,
Danaher Corporation (Leica Microsystem), Fujifilm Holdings Corp., Hologic,
Inc., and Medtronic plc. many others.
ü Needle-Based Biopsy
ü Biopsy Forceps
ü Localization Wires
ü Other Products
ü Breast Biopsy
ü Prostate Biopsy
ü Liver Biopsy
ü Lung Biopsy
ü Kidney Biopsy
ü MRI–guided Biopsy
ü CT scan
By End User
ü Diagnostic and
Middle East &
objective of the Study:
analyze and forecast the Global Biopsy Devices Market size of the market in
terms of value.
examine the careful market segmentation and forecast the market size, in terms
of value, based on the region by segmenting.
Global Biopsy Devices Market segmented into five regions, namely, North
America, Europe, Asia Pacific, Middle East, South America, and their leading
outline, categorized, and forecast the Global Biopsy Devices Market based on By Product Type, By Application, By Imaging
Technology, By End User and By Regional.
examine competitive developments like By
Product Type, By Application, By Imaging Technology, By End User and
by Regional within the Global Biopsy Devices Market.
highlight the impact analysis of the factors affecting the market dynamics such
as growth drivers.
strategically profile the key players and comprehensively analyze their market
shares along with detailing the competitive landscape for market leaders.
Questions Answer by the Report
How will the market drivers, restraints,
and opportunities affect the market dynamics?
What will be the market size in terms of
value and volume and market statistics with a detailed classification?
Which segment dominates the market or
region, and one will be the fastest - growing, and why?
A comprehensive survey of the competitive
landscape and the market participant players
Analysis of strategy adopted by the key
player and their impact on other players.
Scope for the Client
Client satisfaction is our first and last
priority, and that is why BlueWeave Consulting offers customization according
to Company’s specific needs. The following customization options are available
for the report:
• With five additional company detail
• Additional country analysis
• Detailed segment analysis